← All drugs Report issue

ABP-300

mAbexperimentalCOVID-19

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1

0

Phase 2

0

Phase 3

0

Phase 4

0

Mechanism of action

Spike glycoproteinANTAGONIST
Spike glycoprotein antagonist
- Spike glycoprotein (S) ↗

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No